EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Machine Learning‐Based Model for Individualized Prediction of Vancomycin Concentration‐Time Curves in ICU Patients

Jing-Yi Wang, Jiang Hu, Yan Chen, Shan Li, Jin-Min Peng, Run Dong, Xiao-Yun Hu, Wei Jiang, Chun-Yao Wang, Li Weng iD, Bin Du, China Critical Care Clinical Trials Group (CCCCTG)

Pharmacology Research & Perspectives · 2026-04 · 14 (2)

DOI: 10.1002/prp2.70235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 09.03.2026. Verfasst von Jing-Yi Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Intensive Care Unit, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical Co…. Hauptthemen laut MEDLINE: Vancomycin, Drug Monitoring, Anti-Bacterial Agents, Machine Learning. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Clinical Specialty Construction Projects from National Health Commission, National Key R&D Program of China from Ministry of Science and Technology of the People's Republic of China, CAMS Innovation Fund for Medical Sciences (CIFMS) from Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic drug monitoring is essential for ensuring the efficacy and safety of vancomycin therapy in critically ill patients. This study aimed to develop a machine learning model for individualized prediction of vancomycin concentration‐time curves in ICU patients. Adult ICU patients who received intravenous vancomycin and underwent therapeutic drug monitoring at Peking Union Medical College Hospital between January 2014 and December 2023 were retrospectively included. A total of 401 patients were randomly divided into training ( n = 280) and testing ( n = 121) cohorts. Individual pharmacokinetic parameters were estimated using Bayesian posterior inference and served as reference targets. Five machine learning algorithms were evaluated, and the two with the best predictive performance, Lasso Regression and LightGBM, were integrated with a one‐compartment pharmacokinetic model to construct the final predictive model. In the internal testing cohort, the model achieved a mean absolute percentage error (MAPE) of 39.5% for vancomycin concentration prediction. External validation in an independent cohort of 2283 patients showed consistent performance (MAPE = 35.6%). The machine learning‐based model significantly outperformed the classic pharmacokinetic model ( p < 0.001) in both internal and external validations. A user‐friendly software tool based on the model was also developed to facilitate clinical implementation. These findings suggest that the proposed model offers a robust and practical decision‐support tool for optimizing individualized vancomycin dosing in ICU settings. Trial Registration: ClinicalTrials.gov identifier: NCT 06431412

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinDrug MonitoringAnti-Bacterial AgentsMachine LearningHumansIntensive Care UnitsFemalePredictive Learning ModelsMiddle AgedRetrospective StudiesMaleAgedBayes TheoremAdultBoosting Machine Learning AlgorithmsCritical IllnessModels, Biological

Stichwörter der Autor:innen

critical caremachine learningtherapeutic drug monitoringvancomycin

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Medical Intensive Care Unit, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
  • Emergency Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
  • Hangzhou Maicim Medical Tech Co. Ltd., Zhejiang, Hangzhou, China.

ORCID-Profile: Li Weng

Förderung

  • National Key Clinical Specialty Construction Projects from National Health Commission
  • National Key R&D Program of China from Ministry of Science and Technology of the People's Republic of China
  • CAMS Innovation Fund for Medical Sciences (CIFMS) from Chinese Academy of Medical Sciences
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Wang, J. Y., Hu, J., Chen, Y., Li, S., Peng, J. M., Dong, R., Hu, X. Y., Jiang, W., Wang, C. Y., Weng, L., Du, B., & China Critical Care Clinical Trials Group (CCCCTG) (2026). A Machine Learning‐Based Model for Individualized Prediction of Vancomycin Concentration‐Time Curves in ICU Patients. Pharmacology Research & Perspectives, 14(2). https://doi.org/10.1002/prp2.70235

Vancouver

Wang JY, Hu J, Chen Y, Li S, Peng JM, Dong R, et al. A Machine Learning‐Based Model for Individualized Prediction of Vancomycin Concentration‐Time Curves in ICU Patients. Pharmacology Research & Perspectives. 2026;14(2). doi:10.1002/prp2.70235

BibTeX
@article{Wang2026,
  author = {Wang, Jing-Yi and Hu, Jiang and Chen, Yan and Li, Shan and Peng, Jin-Min and Dong, Run and Hu, Xiao-Yun and Jiang, Wei and Wang, Chun-Yao and Weng, Li and Du, Bin and China Critical Care Clinical Trials Group (CCCCTG), China Critical Care Clinical Trials Group (CCCCTG)},
  title = {A Machine Learning‐Based Model for Individualized Prediction of Vancomycin Concentration‐Time Curves in ICU Patients},
  journal = {Pharmacology Research & Perspectives},
  year = {2026},
  volume = {14},
  number = {2},
  doi = {10.1002/prp2.70235}
}
Kostenlos starten →